Hologic Signs Definitive Agreement to Acquire Reveal Genomics
Acquisition would expand Hologic’s oncology diagnostics portfolio to help inform treatment decisions for more women with breast cancer MARLBOROUGH, Mass. — Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops advanced genomic diagnostic tests […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
